Cargando…

SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new viral disease that has gained global attention owing to its ability to provoke community and health-care-associated outbreaks of severe infections in human populations. The virus poses serious challenges to clinical management bec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmoud, Ismail Sami, Jarrar, Yazun Bashir, Alshaer, Walhan, Ismail, Said
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258854/ https://www.ncbi.nlm.nih.gov/pubmed/32479856 http://dx.doi.org/10.1016/j.biochi.2020.05.012

Ejemplares similares

Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges
por: Mahmoud, Ismail Sami, et al.
Publicado: (2021)

Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm
por: Mahmoud, Ismail Sami, et al.
Publicado: (2023)

Analgesics Induce Alterations in the Expression of SARS-CoV-2 Entry and Arachidonic-Acid-Metabolizing Genes in the Mouse Lungs
por: Khirfan, Fatima, et al.
Publicado: (2022)

Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel
por: Odeh, Fadwa, et al.
Publicado: (2019)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
por: Hatmal, Ma’mon M., et al.
Publicado: (2020)

Role of host factors in SARS-CoV-2 entry
por: Evans, John P., et al.
Publicado: (2021)

Roles of host proteases in the entry of SARS-CoV-2
por: Zabiegala, Alexandria, et al.
Publicado: (2023)

Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells
por: Esawi, Ezaldeen, et al.
Publicado: (2021)

SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection
por: Trbojević-Akmačić, Irena, et al.
Publicado: (2021)

The Nudix Hydrolase 15 (NUDT15) Gene Variants among Jordanian Arab Population
por: Jarrar, Yazun Bashir, et al.
Publicado: (2019)

Structural understanding of SARS-CoV-2 virus entry to host cells
por: Le, Kim, et al.
Publicado: (2023)

Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers
por: Jarrar, Yazun Bashir, et al.
Publicado: (2017)

Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications
por: Jarrar, Yazun Bashir, et al.
Publicado: (2019)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Does a host restriction factor facilitate entry of SARS-CoV-2?
por: Gea-Mallorquí, Ester
Publicado: (2020)

A potential role for integrins in host cell entry by SARS-CoV-2
por: Sigrist, Christian JA, et al.
Publicado: (2020)

Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells
por: Millet, Jean Kaoru, et al.
Publicado: (2018)

Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules
por: Al Adem, Kenana, et al.
Publicado: (2020)

1,4-Naphthoquinone Induces FcRn Protein Expression and Albumin Recycling in Human THP-1 Cells
por: Esawi, Ezaldeen Ismael, et al.
Publicado: (2023)

The pros and cons of entry restrictions: are entry restrictions really effective in preventing the spread of SARS-CoV-2?
por: Park, Donghwi, et al.
Publicado: (2022)

Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
por: Nguyen, Hanh T., et al.
Publicado: (2021)

SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
por: Yu, Shi, et al.
Publicado: (2023)

Prevention of host-to-host transmission by SARS-CoV-2 vaccines
por: Mostaghimi, Darius, et al.
Publicado: (2022)

1,4-Naphthoquinone Is a Potent Inhibitor of IRAK1 Kinases and the Production of Inflammatory Cytokines in THP-1 Differentiated Macrophages
por: Mahmoud, Ismail Sami, et al.
Publicado: (2021)

Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
por: Odeh, Fadwa, et al.
Publicado: (2019)

Cell entry mechanisms of SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

SARS-CoV-2, Early Entry Events
por: Chambers, James P., et al.
Publicado: (2020)

Mechanisms of SARS-CoV-2 entry into cells
por: Jackson, Cody B., et al.
Publicado: (2021)

Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2
por: Liu, Ke, et al.
Publicado: (2020)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells
por: Cannalire, Rolando, et al.
Publicado: (2020)

COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells
por: Latini, Andrea, et al.
Publicado: (2020)

Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations
por: Ortiz-Fernández, Lourdes, et al.
Publicado: (2020)

Sex differences in viral entry protein expression and host transcript responses to SARS-CoV-2
por: Sun, Mengying, et al.
Publicado: (2020)

SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids
por: Gyebi, Gideon A., et al.
Publicado: (2021)

Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins
por: You, Jaehwan, et al.
Publicado: (2021)

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
por: Nehlmeier, Inga, et al.
Publicado: (2023)

Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion
por: Nsairat, Hamdi, et al.
Publicado: (2020)

Remote loading of curcumin-in-modified β-cyclodextrins into liposomes using a transmembrane pH gradient
por: Odeh, Fadwa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ujaqndiuiho8kabbginohalvim